Yahoo Search Búsqueda en la Web

Resultado de búsqueda

1. markets.businessinsider.com › news › stocksBristol Myers' 3 Breyanzi Trials Show Consistent Benefit ...

   markets.businessinsider.com › news › stocks

   • En caché

   Hace 20 horas · (RTTNews) - Bristol-Myers Squibb Co. (BMY), Monday announced that data from its three studies and a three-year follow-up from the Phase 3 TRANSFORM trial of Breyanzi showed consistent clinical ...

2. www.morningstar.com › news › business-wireBristol Myers Squibb Presents Multiple New ... - Morningstar

   www.morningstar.com › news › business-wire

   • En caché

   Hace 20 horas · Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO ® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer ...

3. www.placera.se › placera › pressmeddelandenBristol Myers Squibb’s Breyanzi Demonstrates Clinically ...

   www.placera.se › placera › pressmeddelanden

   • En caché

   Hace 20 horas · Bristol Myers Squibb (NYSE: BMY) today announced data from three studies evaluating Breyanzi ® (lisocabtagene maraleucel; liso-cel), including long-term data with three-year follow-up from the Phase 3 TRANSFORM trial of Breyanzi as a second-line treatment in patients with relapsed or refractory large B-cell lymphoma (LBCL), results from a subgroup analysis evaluating the efficacy and safety ...

4. www.itv.com › news › westcountryFloating ecosystem 'islands' launched into Bristol Harbour

   www.itv.com › news › westcountry

   • En caché

   Hace 20 horas · Two floating platforms covered in plants have been launched into Bristol Harbour as part of a £500,000 pound project to help its ecosystem thrive. The islands, which measure around 17m in length ...

5. www.benzinga.com › general › biotechWhy US Drug Giant Bristol Myers Squibb Stock Trading Up On ...

   www.benzinga.com › general › biotech

   • En caché

   Hace 20 horas · Bristol Myers Squibb's KRYSTAL-12 study reveals Krazati's significant benefits over chemotherapy for KRASG12C-mutated NSCLC, improving progression-free survival and response rates.

6. Imágenes

   • 
   • 
   • 
   • 

   Ver todo

7. www.wallstreet-online.de › nachricht › 18155385Bristol Myers Squibb’s Breyanzi Demonstrates Clinically ...

   www.wallstreet-online.de › nachricht › 18155385

   • En caché

   Hace 20 horas · Bristol Myers Squibb (NYSE: BMY) today announced data from three studies evaluating Breyanzi (lisocabtagene maraleucel; liso-cel), including long-term data with three-year follow-up from the Phase ...

8. www.bristolpost.co.uk › news › bristol-newsEmergency services rush to incident in Bristol

   www.bristolpost.co.uk › news › bristol-news

   Hace 20 horas · Emergency services have rushed to the scene of an incident in Bristol this evening (Monday, June 3). The incident is unfolding in the Kingsdown area, located north of the city centre. Avon Fire ...